Correction: Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region
Giaele Moretti, Bruna Vinci, Simona Zito, Alessia Caputo, Francesco Attanasio, Milena Vainieri
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMedication Adherence and Compliance · Venous Thromboembolism Diagnosis and Management · Atrial Fibrillation Management and Outcomes
The Funding statement for this article is incorrect. The correct Funding statement is as follows: The Regional Health Authority of Tuscany under a collaboration agreement with Sant’Anna School program funded the research. The views expressed are those of the author(s) and not necessarily reflect those of the Regional Health Authority.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Moretti G, Vinci B, Zito S, Caputo A, Attanasio F, Vainieri M. Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. P Lo S ONE. 2023;18(9):e 0291628. doi: 10.1371/journal.pone.0291628 37708187 PMC 10501549 · doi ↗ · pubmed ↗